Medical information Clinical review pending

Infection Testing

Parainfluenza 1234 Multiplex Detection Differentiation Quantitative Test

Detects and differentiates between parainfluenza virus types 1, 2, 3, and 4 using quantitative PCR. Helps diagnose respiratory infections, especially in children and those with weakened immune systems.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal aspirates and swabs in viral transport medium, Lung tissues.
Results: Results are typically available within 4 working days. Confirm with the laboratory before booking.
Preparation: Confirm with the laboratory before booking. Ensure you sign the consent document and provide relevant clinical history.

Test priceKSh 23,120

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Parainfluenza 1234 Multiplex Detection Differentiation Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Symptoms of respiratory infection (cough, fever, difficulty breathing)
✓Diagnosis of croup or bronchiolitis
✓Monitoring respiratory illness outbreaks
✓Patients with weakened immune systems
✓Recurrent respiratory infections

In plain language

What this test helps you understand

This test aids in the diagnosis of respiratory infections caused by parainfluenza viruses. Identifying the specific viral type can help guide clinical management and infection control measures.

The Parainfluenza 1234 Multiplex Detection Differentiation Quantitative Test is a diagnostic tool used to identify the specific type of parainfluenza virus causing a respiratory infection. Parainfluenza viruses (types 1, 2, 3, and 4) are common causes of respiratory illnesses, ranging from mild colds to more severe conditions like croup and pneumonia, particularly affecting young children and individuals with compromised immune systems. This test helps healthcare providers determine the exact viral strain involved.

This test uses Real Time RT-PCR technology to measure the amount of each parainfluenza virus type in a respiratory sample. Identifying the specific strain can assist doctors in managing the illness effectively and understanding potential outbreaks.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationConfirm with the laboratory before booking. Ensure you sign the consent document and provide relevant clinical history.

SampleBronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal aspirates and swabs in viral transport medium, Lung tissues.

MethodologyReal Time RT-PCR (Reverse Transcription Polymerase Chain Reaction)

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific parainfluenza virus types. It may not detect other respiratory pathogens. Results should be interpreted in conjunction with clinical findings and other diagnostic tests.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Parainfluenza viruses are a group of viruses that commonly cause respiratory illnesses, especially in children. There are four main types: 1, 2, 3, and 4.

Knowing the specific type can help doctors understand the likely severity of the illness and guide appropriate management, especially in high-risk patients.

Samples can include swabs or aspirates from the nose or throat, sputum, bronchial lavage fluid, or lung tissue, collected in appropriate transport media.

Results are generally available within 4 working days. Confirm with the laboratory before booking.

Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.

You can book the test by calling or WhatsApping us at +254711564616. We have branches across Kenya.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp